欧洲人工角膜和角膜植入物市场预测至 2028 年 - COVID-19 影响和区域分析(按类型(人角膜和人工角膜)、移植类型(穿透性角膜移植术、内皮性角膜移植术等)、疾病适应症(Fuchs\"™ 营养不良、圆锥角膜、真菌性角膜炎等)和最终用户(医院、专科诊所和 ASC 等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 112    |    Report Code: TIPRE00025844    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Artificial Cornea and Corneal Implant Market

市场介绍

人工角膜植入术是消除全部或部分受损角膜并用健康角膜替代的手术供体组织。但目前,全球范围内角膜捐献者短缺,许多国家也没有眼科和组织库。同时,人眼总是有可能排斥移植物,从而导致感染或视力丧失。角膜植入通常在某些条件下进行,例如圆锥角膜、退行性疾病或其他。人造角膜组织可以由诸如二氧化硅材料的聚合物塑料制成。人工角膜植入物有合成角膜植入物和生物合成角膜植入物两种。

 

市场概况和动态

欧洲人造角膜和角膜植入物市场预计到2028年将从1.232亿美元估计增至1.9662亿美元2021 年; 2021年至2028年,复合年增长率可能为7.4%。推动市场增长的关键因素是导致角膜失明的眼病患病率上升,老年人口显着增加是推动人工角膜和角膜植入物的因素市场。然而,昂贵的眼科手术和设备可能会阻碍欧洲人造角膜和角膜植入物市场在预测期内的增长。

发达国家(例如欧洲)老年人口的增加美国、英国以及中国、印度和韩国等发展中国家受到医疗保健设施现代化和医疗服务改善的推动,提高了这些国家的预期寿命。根据联合国《2017年世界人口老龄化》报告,2017年,欧洲60岁以上人口比例全球最高,为25%。此外,到 2050 年,除非洲外,世界所有地区的人口中 60 岁及以上的人数将达到 25% 或以上。视力丧失是老年人的主要健康问题。 65岁时,三分之一的人患有视力受损的眼病。年龄相关性黄斑变性、青光眼、白内障和糖尿病视网膜病变是该年龄段人群视力丧失的最常见原因。年龄相关性黄斑变性导致中央视力丧失。原发性开角型青光眼可能导致视神经损伤和视野丧失。由于这种疾病最初可能无症状,因此老年人应定期检查。尽管白内障是这些人视力问题的常见原因,但摘除白内障的手术通常是成功的。在糖尿病早期或诊断时,糖尿病视网膜病变在老年人中也很常见。当患者被诊断患有糖尿病时,建议进行散瞳检查,此后每年进行一次。因此,老年人口的增加正在推动人工角膜和角膜植入物市场的增长。

在所有欧洲国家,COVID-19 大流行导致生活和角膜植入物大幅减少。已故角膜捐献者和移植。一个国家内不同地点的减少量有所不同,并且对于已故和活着的捐赠者来说也是不同的。在英国,已出现死者捐赠恢复的早期迹象。尽管为抗击疫情投入了大量资源,但国家和移植中心层面仍实施了某些政策修改,以确保移植安全。然而,意大利的角膜移植手术数量连续几个月不断增加,即使增加,也将出现短缺。 COVID-19 大流行对医院服务的影响最为严重。医院里挤满了新冠肺炎 (COVID-19) 患者和其他常规患者。许多角膜捐献专家被重新分配到 ICU 和其他 COVID-19 相关项目中执行各种任务。由于欧洲地区疫情持续,英国、意大利、德国等国家的医院受影响最严重。

 

主要细分市场

欧洲人造角膜和角膜植入物市场根据类型分为人类角膜、人工角膜。到 2021 年,人类角膜细分市场可能会占据最大的市场份额,但人造角膜预计在预测期内将以最高的复合年增长率增长。

欧洲人工角膜和角膜植入物市场根据移植类型分为穿透性角膜移植术、内皮性角膜移植术等。到 2021 年,穿透性角膜移植术可能会占据最大的市场份额,但内皮性角膜移植术预计在未来几年将以最快的速度增长。

欧洲人造角膜和角膜植入物市场按疾病适应症细分为 Fuchs 和角膜植入物市场。营养不良、圆锥角膜、真菌性角膜炎等。福克斯一家营养不良细分市场可能会在 2021 年占据最大的市场份额,但预计真菌性角膜炎细分市场在预测期内的复合年增长率最高。

欧洲人工角膜和角膜植入物市场按最终用户细分为医院、专科诊所和 ASC 等。专科诊所和 ASC 细分市场可能会在 2021 年占据最大的市场份额,预计在预测期内实现最高的市场复合年增长率。

 < /span>

列出的主要来源和公司

一些与本欧洲人造角膜和角膜植入物市场报告相关的主要和次要来源是皇家国家盲人研究所 (RNIB)、西班牙国家统计研究所 (INE) 和卫生部 (MoH)。< /p>

 

购买报告的理由

  • 根据欧洲人工角膜和角膜植入物市场的详细趋势分析确定潜在投资领域
  • 深入了解推动不同成瘾治疗药物需求的潜在因素支出最高的国家,并确定每个国家提供的机会。
  • 加强您对市场需求驱动因素、行业趋势和最新技术发展的了解,
  • 确定推动欧洲人工角膜和角膜植入物市场的主要渠道 < span> 清晰地描绘未来机会,有助于分析,从而实现收入增长。
  • 通过关注不同国家/地区正在进行的项目来引导资源
  • span> 欧洲人工角膜及角膜植入物市场

 

欧洲人工角膜和角膜植入物市场细分

作者

类型

  • 人类角膜
  • 人造角膜

移植类型

  • 穿透性角膜移植术
  • 内皮角膜移植术
  • 其他
  • 按疾病适应症

    • Fuchs’s营养不良
    • 圆锥角膜
    • 真菌性角膜炎
    • 其他

    最终用户

    • 医院
    • 专科诊所和 ASC
    • 其他

    < strong>按国家/地区

    • AJL OPHTHALMIC SA
    • LinkoCare Life Sciences AB< /span>
    • CORNEA BIOSCIENCES, INC
    • EyeYon Medical
    • 佛罗里达狮子眼科银行

     

     

    Europe Artificial Cornea and Corneal Implant Strategic Insights

    Strategic insights for Europe Artificial Cornea and Corneal Implant involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/europe-artificial-cornea-and-corneal-implant-market-strategic-framework.webp
    Get more information on this report

    Europe Artificial Cornea and Corneal Implant Report Scope

    Report Attribute Details
    Market size in 2021 US$ 123.20 Million
    Market Size by 2028 US$ 196.62 Million
    Global CAGR (2021 - 2028) 7.4%
    Historical Data 2019-2020
    Forecast period 2022-2028
    Segments Covered By 类型
    • 人角膜
    • 人工角膜
    By 移植类型
    • 穿透性角膜移植术
    • 内皮角膜移植术
    By 疾病适应症
    • Fuchs营养不良症
    • 圆锥角膜
    • 真菌性角膜炎
    By 最终用户
    • 医院
    • 专科诊所
    • ASC
    Regions and Countries Covered 欧洲
    • 英国
    • 德国
    • 法国
    • 俄罗斯
    • 意大利
    • 欧洲其他地区
    Market leaders and key company profiles
  • AJL OPHTHALMIC S.A
  • LinkoCare Life Sciences AB
  • CORNEA BIOSCIENCES, INC
  • EyeYon Medical
  • Florida Lions Eye Bank
  • Get more information on this report

    Europe Artificial Cornea and Corneal Implant Regional Insights

    The regional scope of Europe Artificial Cornea and Corneal Implant refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-artificial-cornea-and-corneal-implant-market-geography.webp
    Get more information on this report

The List of Companies - Europe Artificial Cornea and Corneal Implant Market

  1. AJL OPHTHALMIC S.A
  2. LinkoCare Life Sciences AB
  3. CORNEA BIOSCIENCES, INC
  4. EyeYon Medical
  5. Florida Lions Eye Bank
Frequently Asked Questions
How big is the Europe Artificial Cornea and Corneal Implant Market?

The Europe Artificial Cornea and Corneal Implant Market is valued at US$ 123.20 Million in 2021, it is projected to reach US$ 196.62 Million by 2028.

What is the CAGR for Europe Artificial Cornea and Corneal Implant Market by (2021 - 2028)?

As per our report Europe Artificial Cornea and Corneal Implant Market, the market size is valued at US$ 123.20 Million in 2021, projecting it to reach US$ 196.62 Million by 2028. This translates to a CAGR of approximately 7.4% during the forecast period.

What segments are covered in this report?

The Europe Artificial Cornea and Corneal Implant Market report typically cover these key segments-

  • 类型 (人角膜, 人工角膜)
  • 移植类型 (穿透性角膜移植术, 内皮角膜移植术)
  • 疾病适应症 (Fuchs营养不良症, 圆锥角膜, 真菌性角膜炎)
  • What is the historic period, base year, and forecast period taken for Europe Artificial Cornea and Corneal Implant Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Artificial Cornea and Corneal Implant Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Europe Artificial Cornea and Corneal Implant Market?

    The Europe Artificial Cornea and Corneal Implant Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • AJL OPHTHALMIC S.A
  • LinkoCare Life Sciences AB
  • CORNEA BIOSCIENCES, INC
  • EyeYon Medical
  • Florida Lions Eye Bank
  • Who should buy this report?

    The Europe Artificial Cornea and Corneal Implant Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Artificial Cornea and Corneal Implant Market value chain can benefit from the information contained in a comprehensive market report.